Comment on Arena Pharmaceuticals Takes a Big Step Forward

Arena Pharmaceuticals Takes a Big Step Forward

Arena Pharmaceuticals (NASDAQ: ARNA) reported positive phase 2 trial results for etrasimod, an S1P modulating drug being studied for use in ulcerative colitis. The results show that 2 mg of etrasimod successfully outperformed placebo in helping ulcerative colitis patients. The data positions the company competitively to vie for market share in this blockbuster indication.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News